These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 25011937)
1. Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response. Fu SH; Lin MH; Yeh LT; Wang YL; Chien MW; Lin SH; Chang DM; Sytwu HK Gut; 2015 May; 64(5):765-75. PubMed ID: 25011937 [TBL] [Abstract][Full Text] [Related]
2. Targeting pre-ligand assembly domain of TNFR1 ameliorates autoimmune diseases - an unrevealed role in downregulation of Th17 cells. Wang YL; Chou FC; Chen SJ; Lin SH; Chang DM; Sytwu HK J Autoimmun; 2011 Nov; 37(3):160-70. PubMed ID: 21689905 [TBL] [Abstract][Full Text] [Related]
3. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis. Terabe F; Fujimoto M; Serada S; Shinzaki S; Iijima H; Tsujii M; Hayashi N; Nomura S; Kawahata H; Jang MH; Miyasaka M; Mihara M; Ohsugi Y; Kishimoto T; Naka T Inflamm Bowel Dis; 2011 Feb; 17(2):491-502. PubMed ID: 20602470 [TBL] [Abstract][Full Text] [Related]
5. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis. Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319 [TBL] [Abstract][Full Text] [Related]
6. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Wakashin H; Hirose K; Maezawa Y; Kagami S; Suto A; Watanabe N; Saito Y; Hatano M; Tokuhisa T; Iwakura Y; Puccetti P; Iwamoto I; Nakajima H Am J Respir Crit Care Med; 2008 Nov; 178(10):1023-32. PubMed ID: 18787221 [TBL] [Abstract][Full Text] [Related]
7. [Immune state of Th1, Th2 and Th17 subpopulation in experimental autoimmune myocarditis]. Han LN; Li TL; Zhang YJ; Yang TS; Ding Y; Guo SL Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):751-6. PubMed ID: 22332535 [TBL] [Abstract][Full Text] [Related]
8. Regulation of gut inflammation and th17 cell response by interleukin-21. Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085 [TBL] [Abstract][Full Text] [Related]
9. Interplay between T(h)1 and T(h)17 effector T-cell pathways in the pathogenesis of spontaneous colitis and colon cancer in the Gαi2-deficient mouse. Götlind YY; Fritsch Fredin M; Kumawat AK; Strid H; Willén R; Rangel I; Bland PW; Hörnquist EH Int Immunol; 2013 Jan; 25(1):35-44. PubMed ID: 22962436 [TBL] [Abstract][Full Text] [Related]
10. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease. Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533 [TBL] [Abstract][Full Text] [Related]
11. T cell-specific BLIMP-1 deficiency exacerbates experimental autoimmune encephalomyelitis in nonobese diabetic mice by increasing Th1 and Th17 cells. Lin MH; Yeh LT; Chen SJ; Chiou HY; Chu CC; Yen LB; Lin KI; Chang DM; Sytwu HK Clin Immunol; 2014 Apr; 151(2):101-13. PubMed ID: 24568746 [TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant serine protease from adult stage of Trichinella spiralis on TNBS-induced experimental colitis in mice. Pang J; Ding J; Zhang L; Zhang Y; Yang Y; Bai X; Liu X; Jin X; Guo H; Yang Y; Liu M Int Immunopharmacol; 2020 Sep; 86():106699. PubMed ID: 32570037 [TBL] [Abstract][Full Text] [Related]
13. TLR2 Involved in Naive CD4+ T Cells Rescues Stress-Induced Immune Suppression by Regulating Th1/Th2 and Th17. Zhao J; Liu J; Denney J; Li C; Li F; Chang F; Chen M; Yin D Neuroimmunomodulation; 2015; 22(5):328-36. PubMed ID: 25721027 [TBL] [Abstract][Full Text] [Related]
15. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment. Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464 [TBL] [Abstract][Full Text] [Related]
16. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. Feili-Hariri M; Falkner DH; Morel PA J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574 [TBL] [Abstract][Full Text] [Related]
17. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene. Ankathatti Munegowda M; Xu S; Freywald A; Xiang J Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785 [TBL] [Abstract][Full Text] [Related]